<html>
<head>
<title>FDA decision to allow over-the-counter hearing loss technology will be a catalyst for innovation | TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">FDA 决定允许非处方听力损失技术将成为创新的催化剂</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2022/08/18/fda-decision-to-allow-over-the-counter-hearing-loss-technology-will-be-a-catalyst-for-innovation/">https://web.archive.org/web/https://techcrunch.com/2022/08/18/fda-decision-to-allow-over-the-counter-hearing-loss-technology-will-be-a-catalyst-for-innovation/</a></blockquote><div><header class="article__header ">
	<p class="article__title-wrapper">
						</p><h1 class="article__title translated">FDA 决定允许非处方听力损失技术将是创新的催化剂</h1>
		

			
	
			
	</header>

			<div class="article-content">
				<p id="speakable-summary" class="translated"><span class="featured__span-first-words">听力损失</span>市场长期以来一直由少数老牌企业主导，由于过时的法规和社会污名，这些企业几乎没有创新的动力。但美国美国食品药品监督管理局的一项新裁决可能会通过推动竞争来彻底改变市场，给创业公司在这一领域取得成功的更大机会。</p>
<p class="translated">周一，美国食品和药物管理局<a href="https://web.archive.org/web/20230225042944/https://www.fda.gov/news-events/press-announcements/fda-finalizes-historic-rule-enabling-access-over-counter-hearing-aids-millions-americans" target="_blank" rel="noopener">宣布</a>助听器和其他听力技术现在可以在柜台销售。这结束了强制开处方的制度，这种制度由于低竞争而导致高成本——更不用说对患者来说是一种耗时且难以操作的努力。听力学领域的创始人和内部人士认为，这一决定将成为催化剂，为听力损失者带来更好的产品和护理。</p>
<p class="translated">约翰霍普金斯大学教授兼听力学和公共卫生交叉领域的研究员尼古拉斯·里德表示，这项裁决将对推动该领域的创新具有里程碑意义。</p>
<p/>			</div>

			</div>    
</body>
</html>